Novo Nordisk to present obesity and diabetes data in Europe
Novo Nordisk said it will present obesity and diabetes data from its Wegovy pill and next-generation treatments at a major European medical conference, as Eli Lilly readies its own obesity updates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.